GlassScriptPhysician profile
John Dempsey Mckee
NPI 1881699767
$6,946.76
in general payments reported to CMS, 2019-2025
22 companies · $1,052 in 2025
The $1,052 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,282 · 2020: $938 · 2021: $1,209 · 2022: $846 · 2023: $925 · 2024: $695 · 2025: $1,052.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,672.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,671.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,220.21 | 2019-2025 | Eluvia, Watchman Flx, Farapulse |
| Abbott Laboratories | $1,687.39 | 2019-2025 | Mitraclip, Jeti Peripheral Catheter, Aveir |
| Edwards Lifesciences Corporation | $1,274.61 | 2019-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Abiomed | $354.36 | 2019-2025 | Impella |
| Janssen Pharmaceuticals, INC | $275.70 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $190.25 | 2019-2025 | |
| Amgen INC. | $120.23 | 2019-2020 | |
| Avinger INC. | $109.56 | 2023 | Pantheris |
| Penumbra, INC. | $109.10 | 2023 | Smart Coil, Indigo System, Penumbra System |
| Pfizer INC. | $101.18 | 2019-2021 | |
| Angiodynamics, INC. | $99.46 | 2025 | Alphavac |
| Teleflex LLC | $65.66 | 2025 | Arrow |
| Livanova USA, INC. | $53.35 | 2023 | Lifesparc |
| Biotronik INC. | $50.80 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $48.65 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $46.20 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $43.75 | 2019 | |
| Cvrx, INC. | $24.10 | 2023 | Barostim Neo System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $21.91 | 2023 | Lifevest |
| Medtronic, INC. | $18.67 | 2022 | |
| Convatec INC. | $16.05 | 2022 | |
| Lantheus Medical Imaging, INC. | $15.57 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Mckee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.